Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation

Fig. 2

METTL1 is elevated in advanced NBLs and is associated with poor prognosis in patients with clinical NBL. A Representative images of METTL1 IHC staining with different staining intensities in clinical NBL tumors. B Quantification of METTL1 IHC scores in different INSS stages of clinical NBL tumors. C Proportion of METTL1expression cases at different stages of clinical NBL tumors. Data are presented as Mean ± SEM. P values were calculated by Kruskal-Wallis test with Dunnett’s multiple comparisons test

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us